Viewing Study NCT02226861


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-27 @ 7:41 AM
Study NCT ID: NCT02226861
Status: COMPLETED
Last Update Posted: 2018-07-05
First Post: 2014-08-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia (ALL) View
None Acute Myelogenous Leukemia (AML) View
None Chronic Lymphocytic Leukemia (CLL) View
None Chronic Myelogenous Leukemia (CML) View
None MDS View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Lymphoblastic Leukemia (ALL) View
None MDS View
None Chronic Myelogenous Leukemia (CML) View
None Chronic Lymphocytic Leukemia (CLL) View
None Acute Myelogenous Leukemia (AML) View